2022 Chemo Cards (Chemotherapy & Targeted Therapies Subcommittee)

The SGO Education Committee's Chemotherapy & Targeted Therapy Subcommittee (2022-2023 Term) updated the 2022 Chemotherapy & Targeted Therapy chemo cards that highlight therapies and offer a “refresher” on dosing, side effects, contraindications, and more. The chemo cards are available as printable PDFs for quick reference in-clinic. Please also access the new and expanded Antineoplastic Therapy for Gynecologic Malignancies – 4TH Edition e-book, which is available on SGO ConnectEd.

Included in this resource are individual PDFs on the following: 

  • Adavosertib
  • Anastrozole
  • Atezolizumab
  • Avelumab
  • Bastilimab
  • Bevacizumab
  • Cediranib
  • Cemiplimab
  • Dostarlimab
  • Durvalumab
  • Everolimus
  • Erlotinib
  • Exemestane
  • Fulvestrant
  • Iplimumab
  • Ixbepilone
  • Letrozole
  • Levonorgestrel 
  • Medroxyprogesterone acetate
  • Megestrol acetate
  • Mirvetuximab 
  • Metformin 
  • Nivolumab
  • Oxaliplatin
  • Oxaliplatin Capecitabine
  • Palbociclib
  • Pazopanib
  • Pembrolizumab
  • Pemrolizumab Lenvatinib
  • Ribociclib
  • Tamoxifen
  • Temsirolimus
  • Trabectedin
  • Trametinib
  • Trastuzumab
  • Tisotumab
  • Zalifrelimab

Keywords: Chemotherapy, targeted therapy, clinical practice, immunotherapy, targeted, flash cards

Target Audience

Physicians, APPs, NPs, RNs

Course summary
Course opens: 
04/28/2023
Course expires: 
05/11/2033
Cost:
$0.00
Rating: 
0

Price

Cost:
$0.00
Please login or register to take this course.